HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lawmakers Introduce Revamped Safe Cosmetics Act

This article was originally published in The Rose Sheet

Executive Summary

Rep. Jan Schakowsky, D-Ill., asserts the anxiously awaited new version of the Safe Cosmetic Act, introduced June 24, incorporates changes with small businesses in mind.

You may also be interested in...



Safe Cosmetics Act Launches, Aimed At “Regulatory Black Hole”

House democrats Markey and Schakowsky have reintroduced The Safe Cosmetics and Personal Care Products Act. The legislation, backed by the Campaign for Safe Cosmetics, claims to close loopholes in federal law to ensure that consumers are not exposed to carcinogens and other hazardous substances through cosmetics use.

House Reps Request Clarification From FDA On Brazilian Blowout Status

FDA has been quiet on the subject of methylene glycol/formaldehyde-containing heated hair-straightening formulas since issuing a warning to Brazilian Blowout marketer GIB in August 2011. House members request an update on the brand’s regulatory status and measures the agency has taken to ensure the safety of salon workers and consumers.

CSC Report: Retailers Should Take Responsibility For Cosmetics Safety

If the federal government won’t keep potentially toxic cosmetics off the market, retailers should, NGO the Campaign for Safe Cosmetics says, scoring eight retailers on their ingredient screening programs and personal-care safety policies.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017633

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel